Most viewed in the last 7 days from @JAMACardio:
Declines in HF-related mortality from 1999 to 2012 have been entirely undone by reversals from 2012 to 2021, meaning that contemporary HF mortality rates are higher than in 1999.
ja.ma/3yduCaX
JAMA Cardiology
14.7K posts
JAMA Cardiology
@JAMACardio
JAMA Cardiology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
- High-intensity statins lower LDL cholesterol in high-risk ASCVD patients, but combining moderate-intensity statins with ezetimibe offers similar benefits with a lower risk of new-onset diabetes and statin intolerance. ja.ma/4gHAk5w @CardioSSoon
- Measurement of coronary artery calcium (CAC) score among adults without ASCVD and of intermediate risk, as well as borderline risk in certain cases, can help refine risk stratification when a clinical decision is uncertain. ja.ma/4in0ADy
- Clopidogrel was associated with reduced risk of thrombotic and bleeding outcomes compared to aspirin. ja.ma/3V6mstM
- Most viewed @JAMAInternalMed article: Clinical Insights review provides an update on the current recommendations for resistant hypertension management. ja.ma/49BwLek
- Clopidogrel was associated with reduced risk of thrombotic and bleeding outcomes compared to aspirin. ja.ma/43Q3YkR
- Cardiac Rehabilitation is an integral and life-prolonging part of the treatment strategy for common cardiovascular diseases. ja.ma/2r8Mdv0
- Higher Lp(a) levels were associated with increased progression of coronary plaque burden and increased presence of low-density noncalcified plaque and pericoronary adipose tissue inflammation. ja.ma/3BoACQ5
- Mavacamten was associated with reductions in biomarkers of cardiac wall stress and injury, with no sustained reductions in LVEF observed in patients with HFpEF and LVEF of 60% or greater. ja.ma/4dljU0X #HFSA2024
- Proof that only one episode of #exercise leads to protection against #cardiovascular events ja.ma/2B6uGXR
- Among older adults with atrial fibrillation receiving apixaban or rivaroxaban, treatment with diltiazem was associated with increased risk of serious bleeding compared with metoprolol. ja.ma/3Q1VkJQ
- Myocardial viability testing does not identify patients with ischemic cardiomyopathy who benefit from PCI. Findings suggest that the extent of dysfunctional yet viable myocardium was not associated with revascularization outcomes. ja.ma/3QFH1vr @REVIVED_BCIS2
- Small RCT (90 pts) finds the use of low-dose DOAC for 3 months after left atrial appendage occlusion was associated with a better balance between efficacy (thromboembolic protection) and safety (major bleeding prevention) compared with DAPT. ja.ma/4dcdDp3
- One month of dual antiplatelet therapy (DAPT) followed by potent P2Y12 inhibitor monotherapy was associated with a reduction in major bleeding without increasing MACCE among patients with ACS undergoing PCI with DES. ja.ma/4f6myJ2
